Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

September 16, 2020

Gastric necrosis after nivolumab therapy in a patient with advanced hepatocellular carcinoma

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Wei-Fan HsuCheng-Yuan Peng
September 16, 2020

A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals

Nature Immunology
Philippos DemetriouMichael L Dustin
September 16, 2020

CD8+ T Cell Infiltration Predicts Chemoradiosensitivity in Nasopharyngeal or Oropharyngeal Cancer

The Laryngoscope
Toshihiko KawaguchiHirohito Umeno
September 16, 2020
Open Access

Checkpoint inhibitors in advanced nonsmall-cell lung cancer; a Bayesian network meta-analysis

Journal of Cancer Research and Therapeutics
Hakan BozcukMehmet Artaç
September 17, 2020

Anti-CD20 treatment for B-cell malignancies: current status and future directions

Expert Opinion on Biological Therapy
Christian KleinTina Nielsen
September 17, 2020
Comment / Editorial

Are We RESPECTing Older Patients With Breast Cancer?

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Evandro de AzambujaRichard D Gelber
September 17, 2020
Case Report

Hypophysitis in granulomatosis with polyangiitis: rare presentation of a multisystem disease

The Journal of the Royal College of Physicians of Edinburgh
Manjunath P RamakrishnaHarish Kumar
September 16, 2020

Pembrolizumab in the preoperative setting of triple-negative breast cancer: safety and efficacy

Expert Review of Anticancer Therapy
Romualdo Barroso-Sousa, Sara M Tolaney
September 17, 2020

Acknowledgment of Reviewers, 2020

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
September 16, 2020

Development of a universal method for the measurement of binding affinities of antibody drugs towards a living cell based on AFM force spectroscopy

Analytical Methods : Advancing Methods and Applications
Hyonchol KimChikashi Nakamura
September 17, 2020

Tumor Lysis Syndrome After a Single Dose of Atezolizumab with Nab-Paclitaxel: A Case Report and Review of Literature

The American Journal of Case Reports
Xavier CarrierAlexander Philipovskiy
September 17, 2020

PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor

Science Signaling
Rachel AmblerChristoph Wülfing
September 17, 2020

The use of immune checkpoint inhibitors in routine oncology

Zeitschrift für Rheumatologie
Julian Schardt
September 16, 2020

Medication-Specific Variations in Morphological Patterns of Injury in Immune Checkpoint Inhibitor-Associated Colitis

Raymond A IsidroAmitabh Srivastava
September 17, 2020
Comment / Editorial

Speed Kills: Advancement in Th17 Cell Adoptive Cell Therapy for Solid Tumors

Cancer Research
Steven N Fiering, Gregory W Ho

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biosensor Development & Applications

Biosensor development and applications describe recent progress in biosensor development and their applications in the field of antibiotics and metabolic engineering. Discover the latest research on biosensor development and applications in this feed.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

© 2020 Meta ULC. All rights reserved